| Date | 2018/12/06 |
|---|---|
| Presentation Theme | Patient-reported outcomes with trastuzumab monotherapy versus trastuzumab plus standard chemotherapy as a postoperative adjuvant therapy in HER2-positive elderly breast cancer patients (RESPECT): A randomized, open-label, phase 3 clinical trial |
| Conference | 2018 San Antonio Breast Cancer Symposium |
| Promoters | San Antonio Breast Cancer Symposium |
| Location | San Antonio, US |
| Conference Type | International |
| Presentation Type | Poster |
| Contribution Type | Collaborative |
| Publisher and common publisher | Kobayashi K, Taira N, Sawaki M, Sagawa N, Baba S, Saito T, Kawahara T, Hagiwara Y, Uemura Y, Shimozuma K, Ohashi Y, Mukai H |